Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Sales

Cellebrite DI (CLBT) EBITDA Margin (2020 - 2025)

Historic EBITDA Margin for Cellebrite DI (CLBT) over the last 6 years, with Q3 2025 value amounting to 15.88%.

  • Cellebrite DI's EBITDA Margin fell 1787100.0% to 15.88% in Q3 2025 from the same period last year, while for Sep 2025 it was 17.19%, marking a year-over-year decrease of 85000.0%. This contributed to the annual value of 24.77% for FY2024, which is 57100.0% up from last year.
  • As of Q3 2025, Cellebrite DI's EBITDA Margin stood at 15.88%, which was down 1787100.0% from 18.74% recorded in Q2 2025.
  • Over the past 5 years, Cellebrite DI's EBITDA Margin peaked at 194.58% during Q3 2024, and registered a low of 79.18% during Q1 2024.
  • For the 5-year period, Cellebrite DI's EBITDA Margin averaged around 16.03%, with its median value being 8.76% (2023).
  • In the last 5 years, Cellebrite DI's EBITDA Margin skyrocketed by 1858200bps in 2024 and then crashed by -1787100bps in 2025.
  • Over the past 5 years, Cellebrite DI's EBITDA Margin (Quarter) stood at 6.34% in 2021, then surged by 74bps to 11.06% in 2022, then tumbled by -236bps to 15.04% in 2023, then surged by 228bps to 19.2% in 2024, then decreased by -17bps to 15.88% in 2025.
  • Its EBITDA Margin was 15.88% in Q3 2025, compared to 18.74% in Q2 2025 and 15.07% in Q1 2025.